Agilent Technologies : Varian Dealogic Deal #  : 636065
Data as of : 7/27/2009
Target Acquiror Dates & Values
Varian Agilent Technologies
Target: 100 % stake Buying: 100 % stake Rumored - Deal Value $m 1,608.3
NS VARI 29 m shares outstanding Public (Listed) Announced 27th Jul 2009 Value ex Debt $m 1,608.3
United States United States
Healthcare Technology Expected 27th Nov 2009 Consideration
JPMorgan | Advisor Completed -
JPMorgan | Fairness Opinion
Cravath Swaine & Moore | Attorney Withdrawn -
Termination Fee, Target $m 46
Termination Fee, Acquiror $m tbd
Financials 3rd Apr 2009
Balance Sheet Debt/Equity: 0.5
Timeline Events Premiums & Multiples
Initial Offer $52.00
Current Offer $52.00
Income Statement
Cash Flows
Operations $m 100
Profitability
Profit Margin 6%
Return on Equity 5%
League Table Impact Sector Trend
2009 YTD Announced Global M&A by Deal Value, $bn Monthly Announced Global M&A, $bn: Healthcare
1 Goldman Sachs 381.9
2 Morgan Stanley 374.6
3 JPMorgan 339.9
4 Citi 256.1
5 Lazard 219.4
6 BOA Merrill Lynch 213.3
7 Deutsche Bank 202.6
8 UBS 166.3
9 Credit Suisse 150.0
10 Barclays Capital 127.5
© 2009 Dealogic.  All rights reserved.